Sean P. Nolan - Net Worth and Insider Trading
Sean P. Nolan Net Worth
The estimated net worth of Sean P. Nolan is at least $5 Million dollars as of 2024-11-29. Sean P. Nolan is the CEO of Taysha Gene Therapies Inc and owns about 1,536,715 shares of Taysha Gene Therapies Inc (TSHA) stock worth over $5 Million. Sean P. Nolan is also the President & CEO of AveXis Inc and owns about 0 shares of AveXis Inc (AVXS) stock worth over $0. Details can be seen in Sean P. Nolan's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Sean P. Nolan has not made any transactions after 2023-08-16 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Sean P. Nolan
Sean P. Nolan Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Sean P. Nolan owns 5 companies in total, including Taysha Gene Therapies Inc (TSHA) , Ventas Inc (VTR) , and Neoleukin Therapeutics Inc (NLTX) among others .
Click here to see the complete history of Sean P. Nolan’s form 4 insider trades.
Insider Ownership Summary of Sean P. Nolan
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| TSHA | Taysha Gene Therapies Inc | 2023-08-16 | director |
| VTR | Ventas Inc | 2019-07-26 | director |
| NLTX | Neoleukin Therapeutics Inc | 2019-10-10 | director |
 | | 2018-05-15 | director & President & CEO |
| | 2021-09-24 | director |
Sean P. Nolan Latest Holdings Summary
Sean P. Nolan currently owns a total of 2 stocks. Among these stocks, Sean P. Nolan owns 1,536,715 shares of Taysha Gene Therapies Inc (TSHA) as of August 16, 2023, with a value of $5 Million and a weighting of 100%. Sean P. Nolan also owns 0 shares of AveXis Inc (AVXS) as of March 7, 2018, with a value of $0 and a weighting of 0%.
Latest Holdings of Sean P. Nolan
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| TSHA | Taysha Gene Therapies Inc | 2023-08-16 | 1,536,715 | 3.00 | 4,610,145 |
| AVXS | AveXis Inc | 2018-03-07 | 0 | 217.83 | 0 |
Holding Weightings of Sean P. Nolan
Sean P. Nolan Form 4 Trading Tracker
According to the SEC Form 4 filings, Sean P. Nolan has made a total of 2 transactions in Taysha Gene Therapies Inc (TSHA) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Taysha Gene Therapies Inc is the acquisition of 444,444 shares on August 16, 2023, which cost Sean P. Nolan around $400,000.
According to the SEC Form 4 filings, Sean P. Nolan has made a total of 0 transactions in AveXis Inc (AVXS) over the past 5 years. The most-recent trade in AveXis Inc is the sale of 10,000 shares on March 7, 2018, which brought Sean P. Nolan around $1 Million.
Insider Trading History of Sean P. Nolan
- 1
Sean P. Nolan Trading Performance
GuruFocus tracks the stock performance after each of Sean P. Nolan's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Sean P. Nolan is -20.25%. GuruFocus also compares Sean P. Nolan's trading performance to market benchmark return within the same time period. The performance of stocks bought by Sean P. Nolan within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Sean P. Nolan's insider trading performs compared to the benchmark.
Performance of Sean P. Nolan
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 44.7 | | | | | |
| Relative Return to S&P 500(%) | 44.09 | | | | | |
Sean P. Nolan Ownership Network
Sean P. Nolan Owned Company Details
What does Taysha Gene Therapies Inc do?
Who are the key executives at Taysha Gene Therapies Inc?
Sean P. Nolan is the director of Taysha Gene Therapies Inc. Other key executives at Taysha Gene Therapies Inc include director & 10 percent owner Paul B Manning , Chief Financial Officer Kamran Alam , and 10 percent owner Session R.a. Ii .
Taysha Gene Therapies Inc (TSHA) Insider Trades Summary
Over the past 18 months, Sean P. Nolan made 1 insider transaction in Taysha Gene Therapies Inc (TSHA) with a net purchase of 444,444. Other recent insider transactions involving Taysha Gene Therapies Inc (TSHA) include a net purchase of 17,900,000 shares made by Paul B Manning , a net sale of 549,095 shares made by Session R.a. Ii , and a net purchase of 777,778 shares made by Stalfort John A Iii .
In summary, during the past 3 months, insiders sold 0 shares of Taysha Gene Therapies Inc (TSHA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 582,095 shares of Taysha Gene Therapies Inc (TSHA) were sold and 19,233,333 shares were bought by its insiders, resulting in a net purchase of 18,651,238 shares.
Taysha Gene Therapies Inc (TSHA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Taysha Gene Therapies Inc Insider Transactions
Sean P. Nolan Mailing Address
Above is the net worth, insider trading, and ownership report for Sean P. Nolan. You might contact Sean P. Nolan via mailing address: C/o Intermune, Inc., 3280 Bayshore Blvd., Brisbane Ca 94005.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
